Chemoattractants such as CCL2 (or MCP1), secreted by cancer cells, can stimulate microglia via CCR2 activation, and recruit the microglia to the tumor microenvironment to support invasiveness through IL-6 expression (8). Here, IL6 is linked to cancer.